Literature DB >> 26729208

Improving acute kidney injury management in lower limb arthroplasty: an educational approach.

Alistair I W Mayne1, Neville W Thompson2.   

Abstract

INTRODUCTION: Acute kidney injury (AKI) is a common but preventable cause of morbidity in elective arthroplasty patients. This study aimed to review the incidence and management of AKI in patients undergoing elective lower limb arthroplasty and compare results to those after the introduction of educational measures to improve prevention, recognition and management of AKI.
METHODS: A retrospective case note review of all patients undergoing elective hip or knee arthroplasty between August and October 2013 was performed. Results were compared to patients treated from February to April 2014, after the introduction of a renal protection protocol, checklist poster and educational sessions. Results were statistically compared using Fisher's exact test.
RESULTS: Two hundred and eleven patients were included in the study: 104 in the initial cohort and 107 in the second cohort. Twenty patients (19.2 %) developed AKI in the initial cohort and 12 patients (11.2 %) in the second (p = 0.13). Recognition, documentation and management of AKI were significantly better following educational sessions and dissemination of posters throughout clinical areas, with 75 % of patients in the second cohort having their AKI documented and treated versus 30 % in the initial cohort. DISCUSSION/
CONCLUSIONS: This quality improvement project has demonstrated the significant impact that simple educational measures can have on improving AKI prevention, recognition and management in patients undergoing elective arthroplasty surgery. The introduction of a logical treatment checklist has been well received by both medical and nursing staff and ensures prompt and efficient management of AKI in a non-specialist area.

Entities:  

Keywords:  Acute kidney injury; Arthroplasty; Audit; Education; Quality improvement

Mesh:

Year:  2016        PMID: 26729208     DOI: 10.1007/s00590-015-1734-y

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  7 in total

1.  KDIGO clinical practice guidelines for acute kidney injury.

Authors:  Arif Khwaja
Journal:  Nephron Clin Pract       Date:  2012-08-07

2.  Get basics right to improve acute kidney injury, says consensus conference.

Authors:  Bryan Christie
Journal:  BMJ       Date:  2012-11-21

3.  Acute kidney injury following total joint arthroplasty: retrospective analysis.

Authors:  Toby N Weingarten; Carmelina Gurrieri; Paul D Jarett; Deforest R Brown; Novette J Berntson; Reynaldo D Calaro; Daryl J Kor; Daniel J Berry; Vesna D Garovic; Wayne T Nicholson; Darrell R Schroeder; Juraj Sprung
Journal:  Can J Anaesth       Date:  2012-09-29       Impact factor: 5.063

4.  Renal impairment following total joint arthroplasty: who is at risk?

Authors:  S Mehdi Jafari; Ronal Huang; Ashish Joshi; Javad Parvizi; William J Hozack
Journal:  J Arthroplasty       Date:  2010-05-31       Impact factor: 4.757

5.  Antibiotic-related acute kidney injury in patients undergoing elective joint replacement.

Authors:  O Bailey; M S Torkington; I Anthony; J Wells; M Blyth; B Jones
Journal:  Bone Joint J       Date:  2014-03       Impact factor: 5.082

6.  Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement.

Authors:  Sudhakar Rao Challagundla; David Knox; Amanda Hawkins; David Hamilton; Robert W V Flynn; Sue Robertson; Chris Isles
Journal:  Nephrol Dial Transplant       Date:  2012-11-29       Impact factor: 5.992

7.  Acute Kidney Injury: It's as easy as ABCDE.

Authors:  Caroline Forde; Jennifer McCaughan; Niall Leonard
Journal:  BMJ Qual Improv Rep       Date:  2012-12-18
  7 in total
  1 in total

1.  The Incidence and Risk Factors of Acute Kidney Disease after Total Knee Arthroplasty with Early Postoperative Volume Supplement.

Authors:  Kuan-Ting Wu; Chung-Yang Chen; Bradley Chen; Jun-Wen Wang; Po-Chun Lin; Shih-Hsiang Yen
Journal:  Biomed Res Int       Date:  2018-07-17       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.